Department of Surgery, Maastricht University Medical Centre, NUTRIM School of Nutrition, Toxicology and Metabolism, Maastricht University, The Netherlands.
Aliment Pharmacol Ther. 2012 Apr;35(8):921-8. doi: 10.1111/j.1365-2036.2012.05044.x. Epub 2012 Feb 23.
A simulated upper gastrointestinal (UGI) bleed in cirrhotic patients has been shown to induce hyperammonaemia. The kidney was the site of this exaggerated ammoniagenesis with alanine as substrate. Administration of alanine to decompensated cirrhotic patients did not change hepatic gluconeogenesis, but resulted in increased ammoniagenesis. We hypothesise that reduced hepatic glycogen stores result in hyperglucagonaemia which may drive increased renal gluconeogenesis and therefore alanine uptake and renal ammoniagenesis.
To determine whether an overnight glucose infusion lowers renal ammoniagenesis by reducing hyperglucagonaemia and renal ammoniagenesis.
Patients with decompensated cirrhosis were studied in a cross-over design. An UGI bleed was simulated via intragastric administration of an amino acids mixture mimicking the haemoglobin molecule after a 12-h overnight fast (F-group) or after a 12-h treatment with 20% glucose solution (G-group).
Before the simulated bleed the glucagon levels were 21 (15-31) pmol/L in the F-group and 15 (9-21) pmol/L in the G-group (P < 0.01). After the simulated bleed, arterial ammonia levels increased in both groups [F-group: 73-118 μmol/L (P = 0.01); G-group 64-87 μmol/L (P = 0.01)]. The enhancement of hyperammonaemia was significantly higher in the F-group (45 [19-71] μmol/L) compared with the G-group (23 [13-39] μmol/L) (P = 0.01). The difference in renal ammoniagenesis during the simulated bleed in the F-group was 399 (260-655) nmol/kg/bwt/min and was significantly higher than in the G-group 313 (1-498) nmol/kg/bwt/min (P = 0.05).
Overnight glucose infusion results in reduced renal ammoniagenesis and attenuates ammonia levels. These observations have implications for the development of nutritional strategies in hyperammonaemic patients.
在肝硬化患者中模拟上消化道出血已被证明可引起高血氨症。肾脏是这种以丙氨酸为底物的过度氨生成的部位。给肝功能失代偿的肝硬化患者输注丙氨酸不会改变肝糖异生,但会导致氨生成增加。我们假设肝糖原储存减少导致高胰高血糖素血症,这可能导致肾脏糖异生增加,从而导致丙氨酸摄取和肾脏氨生成增加。
通过降低高胰高血糖素血症和肾脏氨生成来确定夜间葡萄糖输注是否会降低肾脏氨生成。
采用交叉设计对肝功能失代偿的肝硬化患者进行研究。通过胃内给予模拟血红蛋白分子的氨基酸混合物模拟上消化道出血,在 12 小时禁食过夜(F 组)或在 12 小时 20%葡萄糖溶液治疗后(G 组)进行。
在模拟出血前,F 组的胰高血糖素水平为 21(15-31)pmol/L,G 组为 15(9-21)pmol/L(P <0.01)。在模拟出血后,两组的动脉血氨水平均升高[F 组:73-118 μmol/L(P = 0.01);G 组:64-87 μmol/L(P = 0.01)]。F 组高氨血症的增强程度明显高于 G 组[45(19-71)μmol/L 比 23(13-39)μmol/L](P = 0.01)]。F 组在模拟出血期间的肾脏氨生成差异为 399(260-655)nmol/kg/bwt/min,明显高于 G 组的 313(1-498)nmol/kg/bwt/min(P = 0.05)。
夜间葡萄糖输注可导致肾脏氨生成减少,并降低血氨水平。这些观察结果对高氨血症患者营养策略的发展具有重要意义。